Growth of MDA-MB-231 cell line: different effects of TGF-beta(1), EGF and estradiol depending on the length of exposure

Cell Biol Int. 1998;22(9-10):679-84. doi: 10.1006/cbir.1998.0306.

Abstract

The human cell line MDA-MB-231 is a prototype for the study of hormone-independent breast cancer. Modification of cell growth behaviour has been observed after treating these cells with growth factors. EGF is a typical stimulatory growth factor for many cell types, whereas transforming growth factor beta(1)(TGF-beta(1)) acts with inhibitory character. Here we observed cell growth inhibition after EGF as well as after TGF-beta(1)treatments. Nevertheless, in the 42-h experiments, EGF-treated cultures grew before (18 hours) respect to the TGF-beta(1)and E(2)-treated cultures (24 h), and in the 11-day experiments, EGF-treated cultures started growing (7 days) after TGF-beta(1)-treated cultures (5 days). Estradiol inhibited the proliferation of these cells only after several days of treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / pathology*
  • Breast Neoplasms / physiopathology
  • Cell Division / drug effects
  • Cell Division / physiology
  • Epidermal Growth Factor / pharmacology*
  • Epidermal Growth Factor / physiology
  • Estradiol / pharmacology*
  • Estradiol / physiology
  • Female
  • Humans
  • Signal Transduction
  • Time Factors
  • Transforming Growth Factor beta / pharmacology*
  • Transforming Growth Factor beta / physiology
  • Tumor Cells, Cultured

Substances

  • Transforming Growth Factor beta
  • Estradiol
  • Epidermal Growth Factor